Kalinin R E, Suchkov I A, Chobanian A A, Nikiforov A A, Dmitrieva M N, Isakov S A
I.P. Pavlov Ryazan State Medical University of the RF Ministry of Public Health, Ryazan, Russia.
Angiol Sosud Khir. 2021;27(2):17-24. doi: 10.33529/ANGIO2021203.
The purpose of the study was to determine the level of substances damaging the vascular endothelium, as well as to assess their effect on the functional state of the endothelium and the course of obliterating atherosclerosis of lower limb arteries.
The study included a total of 112 people, subdivided into three groups: those with an unfavourable course of obliterating atherosclerosis of lower limbs arteries (n=48) - group 1, patients with obliterating atherosclerosis of lower limbs arteries with a conventionally favourable course (n=48) - group 2, and apparently healthy volunteers (n=16). In all subjects, the following parameters were analysed: stable metabolites of nitric oxide II, endothelin-1, homocysteine and basal insulin.
The level of stable nitric oxide metabolites (p<0.001 as compared with group 1; p<0.045 compared with group 2) was lower in the groups of patients with obliterating atherosclerosis of lower limb arteries (88.5±7.3 μmol/L in group 1; 161.5±8.6 μmol/L in group 2) as compared with healthy volunteers (226.0±28.6 μmol/L). In its turn, the level of nitric oxide was statistically significantly lower (p<0.001) in group 1 patients as compared with those of group 2. The level of endothelin-1 turned out to be higher (p<0.001) in group 1 (2.1±0.1 ng/ml) as compared with group 2 (1.6±0.1 ng/ml). Comparing group 1 patients with healthy volunteers (1.4±0.1 ng/ml), the level of endothelin-1 had also higher values (p<0.001). The level of endothelin-1 did not differ (p=0.270) as compared with group 2 and healthy volunteers. Comparing the homocysteine level in patients of the examined groups (20.7±0.8 μmol/L in group 1 patients and 18.1±0.6 μmol/L in group 2 patients) with healthy volunteers (13.0±0.4 μmol/L) demonstrated an increase in the parameters (p<0.001). The level of homocysteine turned out to be higher in group 1 patients than in those of group 2 (p<0.001). The level of basal insulin turned out to be significantly higher in the studied groups of patients with obliterating atherosclerosis of lower limb arteries (24.9±4.6 mIU/L in group 1; 8.0±0.7 mIU/L in group 2) than in healthy volunteers (5.1±0.5 mIU/L). Statistically significant (p<0.001) hyperinsulinemia was observed in group 1 as compared with group 2.
Hyperhomocysteinemia and hyperinsulinemia are predictors of an unfavourable course of the disease. In a high level of these parameters, one may predict an unfavourable course of obliterating atherosclerosis of lower limb arteries.
本研究旨在确定损伤血管内皮的物质水平,并评估其对内皮功能状态及下肢动脉闭塞性动脉粥样硬化病程的影响。
本研究共纳入112人,分为三组:下肢动脉闭塞性动脉粥样硬化病情不利的患者(n = 48)——第1组;下肢动脉闭塞性动脉粥样硬化病情常规有利的患者(n = 48)——第2组;以及明显健康的志愿者(n = 16)。对所有受试者分析以下参数:一氧化氮II的稳定代谢产物、内皮素-1、同型半胱氨酸和基础胰岛素。
与健康志愿者(226.0±28.6 μmol/L)相比,下肢动脉闭塞性动脉粥样硬化患者组(第1组88.5±7.3 μmol/L;第2组161.5±8.6 μmol/L)中一氧化氮稳定代谢产物水平较低(与第1组相比,p<0.001;与第2组相比,p<0.045)。相应地,第1组患者的一氧化氮水平与第2组相比在统计学上显著更低(p<0.001)。第1组(2.1±0.1 ng/ml)的内皮素-1水平高于第2组(1.6±0.1 ng/ml)(p<0.001)。将第1组患者与健康志愿者(1.4±0.1 ng/ml)比较,内皮素-1水平也更高(p<0.001)。与第2组和健康志愿者相比,内皮素-1水平无差异(p = 0.270)。将所检查组患者(第1组患者同型半胱氨酸水平为20.7±0.8 μmol/L,第2组患者为18.1±0.6 μmol/L)与健康志愿者(13.0±0.4 μmol/L)的同型半胱氨酸水平比较,这些参数有所升高(p<0.001)。第1组患者的同型半胱氨酸水平高于第2组患者(p<0.001)。在研究的下肢动脉闭塞性动脉粥样硬化患者组中,基础胰岛素水平显著高于健康志愿者(第1组24.9±4.6 mIU/L;第2组8.0±0.7 mIU/L;健康志愿者5.1±0.5 mIU/L)。与第2组相比,第1组观察到具有统计学意义(p<0.001)的高胰岛素血症。
高同型半胱氨酸血症和高胰岛素血症是疾病病情不利的预测指标。这些参数处于高水平时,可预测下肢动脉闭塞性动脉粥样硬化的病情不利。